1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow leniolisib: new trials by email Literature Review of leniolisib trials Research Report on leniolisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI CDZ173 - Activated PI3Kdelta Syndrome (APDS); PASLI Disease | Phase 2 / Phase 3 | Terminated | Pharming Technologies B.V. | 37 | 2016-09-08 | 2026-03-30 |
Activated PI3K-delta Syndrome (1) · Immunologic Deficiency Syndromes (1) · Lymphadenopathy (1)
Pharming Technologies B.V. (1)
Belarus (1) · Czechia (1) · Germany (1) · Italy (1) · Netherlands (1) · Russia (1) · United States (1)
2016 (1)